Wodehouse
Capital leads transaction advisory, supporting OIC’s strategic entry into India
Medi-Mold,
a leading manufacturer of medical-grade molds and precision tooling based
within the Andhra Pradesh MedTech Zone (AMTZ), has entered into a strategic
partnership with OIC International (USA) and AddUp (France) to establish a
state-of-the-art 3D printed orthopaedic implant manufacturing facility in
Vizag, India.
The
memorandum of understanding for this strategic collaboration was signed in New
Delhi in the presence of Mr. Ajay Sood, Principal scientific adviser to the
Government of India (PMO Office, New Delhi).
The
partnership brings together US-based OIC’s FDA-approved implant technology,
French additive manufacturing systems, and India’s largest MedTech ecosystem
(AMTZ). A dedicated manufacturing line will be set up within AMTZ to produce
3D-printed orthopaedic implants across trauma, spine, hip, and other segments.
Shri
Shetty, Co-Founder & CEO, OIC International said, “This partnership strengthens our commitment
to India and enables us to bring world-class, FDA-approved, 3D printed
orthopaedic implants to one of the fastest-growing markets globally.”
As part of
the transaction, Medi-Mold has agreed to an investment outlay of INR over 100
crores towards OIC International’s setup, India entry, manufacturing, and
expansion plans. The capital will be deployed to set up and scale the 3D
printed implants facility and localize production, thereb y reducing India’s
reliance on imports. It will also support the transfer of proprietary
technology, patents, and manufacturing SOPs, and the development of a
specialized workforce for advanced MedTech manufacturing.
The facility will leverage AMTZ’s advanced testing labs, machining
centres, and regulatory infrastructure to produce high-quality implants
at globally competitive costs. This entire initiative is well supported by Dr.
Jitendra Sharma, AMTZ.
Dr.
Teja, Chief Executive Officer from Medi-Mold added, “AMTZ and Medi Mold are proud to host this technologically
advanced facility, aligning with India’s vision of becoming a global MedTech
manufacturing hub.”
Wodehouse
Capital Advisors acted as the exclusive financial and India market entry
advisor to OIC for this transaction. The firm supported the evaluation of
suitable partners, the structuring of the commercial arrangement, and the
overall approach for OIC’s expansion into India. This marks Wodehouse Capital’s
fifth healthcare transaction in the last 12 months, reflecting its continued
work across the healthcare sector in segments such as medical devices,
diagnostics, and single-specialty healthcare services.
Sraboni
Haralalka, Executive Director, Wodehouse Capital Advisors said, “We are delighted to have advised on
this marquee cross-border transaction. This collaboration sets the stage for
India to emerge as a global center for advanced orthopaedic implant
manufacturing.”
About
the Partners
OIC
International (USA):
A global healthcare company specialising in
FDA-approved, 3D printed orthopaedic implants supported by 40+ approvals and
multiple patents.
Medi-Mold
/ AMTZ (India):
A leading precision tooling manufacturer within the Andhra Pradesh
MedTech Zone — India’s largest integrated MedTech manufacturing ecosystem. This
entire initiative is well supported by Dr Jitendra Sharma.
AddUp
(France):
A subsidiary of the billion-dollar Fives Group and a global leader in
industrial metal additive manufacturing technologies.
Wodehouse
Capital Advisors (India):
Wodehouse Capital Advisors is a mid-market focused global
investment bank, driving high-impact M&A, fund-raising, strategic
partnerships, and India market entry mandates. With a proven track record
of 50+ successful transactions across Healthcare, Industrials,
Consumer and Business Services. WCA combine deep sector expertise with
large-scale investor access to deliver high-impact outcomes.
